We love to hear from our listeners. Send us a message. On Episode 127 of Cell & Gene: The Podcast, Carlos Buesa, Ph.D., Founder and Chairman of the Board at Oryzon talks to Host Erin Harris about how targeting LSD1 is unlocking new treatment approaches across oncology, CNS disorders, and sickle cell disease, with promising early clinical data and a strategy grounded in precision epigenetics. Subscribe to the podcast! Apple | Spotify | YouTube Visit my website: Cell &...
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.
Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka
Scaling CRISPR for Rare Disease with Aurora Therapeutics' Dr. Edward Kaye
Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous
Free AI-powered recaps of Cell & Gene: The Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.